Mia's Feed
Medical News & Research

Link Between Blood Vessel Dysfunction and Muscle Wasting in Cancer Patients

Link Between Blood Vessel Dysfunction and Muscle Wasting in Cancer Patients

Share this article

New research uncovers how blood vessel dysfunction contributes to muscle wasting in cancer, pointing to potential new treatments to improve patient strength and outcomes.

2 min read

A recent study from the University of Illinois Chicago has highlighted a significant connection between impaired blood vessel function and muscle wasting, known as cachexia, in cancer patients. The research suggests that poor blood vessel health within muscles contributes to weakness and weight loss commonly seen in metastasis and advanced stages of cancer.

Blood vessels are essential not only for delivering nutrients and oxygen to muscles but also for maintaining overall organ health. The study utilized high-resolution 3D microscopy in animal models of various cancers, including pancreatic, colon, lung, and melanoma. Findings revealed that muscles affected by cachexia had fewer and less healthy blood vessels, alongside reduced muscle mass and thinner fibers, resulting in diminished strength.

Further analysis showed that endothelial cells lining the blood vessels in cachectic muscles exhibited signs of aging, increased leakiness, and higher rates of cell death. A key molecule called activin A was found to be elevated in these endothelial cells, which suppressed the expression of PGC1α, a protein vital for blood vessel health and muscle integrity. Restoring PGC1α levels improved blood vessel function and muscle strength, indicating a potential therapeutic target.

The research highlights that vascular dysfunction plays a critical role in the progression of cachexia, and addressing this could help improve muscle function and patient outcomes. Currently, there are no FDA-approved treatments specifically targeting cachexia, and conventional approaches like nutrition and exercise often fall short. Future therapies aimed at modulating activin A and PGC1α levels in blood vessels are promising avenues for combating muscle wasting in cancer patients.

Understanding the role of blood vessels in muscle health opens new pathways for treatment, with the potential to enhance quality of life and survival rates among cancer sufferers. The study emphasizes that maintaining healthy vasculature is crucial in preventing and potentially reversing muscle wasting associated with cancer.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Blocking Minor Splicing: A Promising Approach to Hindering Tumor Growth Across Multiple Cancer Types

Australian researchers have identified a new approach to slow down tumor growth across multiple cancers by inhibiting minor splicing. This strategy activates cancer cell death pathways while largely sparing healthy cells, offering a promising avenue for broad-spectrum cancer treatment.

Revolutionary Approach Reprograms Stem Cells to Produce Durable Cancer-Fighting T Cells

UCLA researchers have pioneered a method to reprogram blood stem cells to produce a renewable source of cancer-fighting T cells, opening new possibilities in immunotherapy for hard-to-treat cancers.

Innovative Stem Cell Transplant Eliminates Toxic Prep in Genetic Disease Treatment

Stanford Medicine researchers developed a safe and effective antibody-based method to perform stem cell transplants for genetic blood disorders without toxic chemotherapy or radiation, significantly improving patient outcomes.

Vaccine Leadership Resignations Amid Declining Childhood Immunization Rates

Resignations of key CDC officials and declining childhood vaccination rates raise concerns about the future of immunization efforts and public health safety amid rising vaccine skepticism.